Coronary Restenosis: Clinical Trials

107 trials for Coronary Restenosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

74 completed, 14 unknown, 8 recruiting, 4 terminated. 31 Not applicable, 20 Phase 4, 13 Phase 3, 12 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable31Completed 21, Unknown 4, Withdrawn 2, Active not recruiting 1, Recruiting 1, Suspended 1, Terminated 1
Phase 420Completed 16, Unknown 3, Terminated 1
Phase 313Completed 11, Unknown 2
Phase 212Completed 11, Terminated 1
Phase 14Completed 4

Follow Coronary Restenosis: new trials by email Literature Review of Coronary Restenosis trials Research Report on Coronary Restenosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The PICCOLETO XIII REVEAL-DCB Cohort A Study
Coronary Artery Disease, Coronary Stenosis
Not yet recruitingFondazione Ricerca e Innovazione Cardiovascolare ETS2002026-10-012026-10-09
Disease Characteristics of R-CAD
Protocol-defined Examinations and Evaluations - Coronary Artery Disease, Coronary Artery Disease Progression
Not yet recruitingPeking Union Medical College Hospital522025-11-012025-11-28
Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.
DEB - Coronary Arterial Disease (CAD), Restenosis, Coronary
RecruitingOlivier F. Bertrand15002025-06-102026-04-20
Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study
Healthy life style, Secondary prevention for atherosclerotic coronary artery disease, Immunosuppressive Therapy - Coronary Artery Disease, Coronary Artery Disease Progression
RecruitingPeking Union Medical College Hospital1202025-04-012025-11-19
Disease Characteristics of IR-CAD: a Case-control Study
Protocol-defined Examinations - Coronary Artery Disease, Coronary Artery Stenosis
RecruitingPeking Union Medical College Hospital302023-11-022025-11-19
AnGiographic Performance With A Sirolimus-elutiNG Balloon in the TrEatment of De Novo CoronaRy Artery Disease
Magic Touch SCB by Concept Medical Inc. - Coronary Restenosis
Not applicableCompletedFondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS1102023-05-232025-12-03
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
Healthy life style, Secondary prevention for atherosclerotic coronary artery disease, Immunosuppressive therapy - Coronary Artery Disease, Coronary Artery Stenosis
RecruitingPeking Union Medical College Hospital392023-05-172025-11-19
Resveratrol Excipient Paclitaxel Coated Balloon for Coronary Treatment
SeQuent Please ReX, Plain old balloon angioplasty (POBA) - In-stent Coronary Artery Restenosis, Coronary Artery Restenosis
Not applicableWithdrawnB. Braun Medical Inc.2023-02-102023-02-14
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
Drug eluting stent (DES), Drug coated ballloon (DCB) - Coronary Artery Disease, Restenoses, Coronary
Not applicableRecruitingDeutsches Herzzentrum Muenchen3762022-09-282025-01-06
STAR and Deferred Stenting Study
Stent Placement Timing - Early, Stent Placement Timing - Late - Coronary Occlusion, Coronary Stenosis
Not applicableCompletedSaint Luke's Health System1502021-11-232025-10-24
COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease
Impact of current PCI techniques/ devices in complex coronary artery lesions - Coronary Disease, Coronary Artery Disease
RecruitingLuzerner Kantonsspital50002021-11-012024-10-29
Drug Eluting Balloon Angioplasty Versus Everolimus Platinum Chrome Stent
DEB for de Novo Lesions, DES for de Novo Lesions - Percutaneous Coronary Intervention (PCI), Coronary Artery Disease (CAD)
Not applicableUnknownGeneral Administration of Military Health, Tunisia2902021-08-252022-08-25
SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters
Sirolimus Eluting Balloon - Coronary Disease, Coronary Artery Disease
RecruitingLuzerner Kantonsspital20002021-06-012024-10-29
Physiology and Residual Ischemia After Percutaneous Coronary Intervention
Ischemic Heart Disease, Angina Pectoris
UnknownLaval University2602021-02-182022-01-31
Abbott Vascular Medical Device Registry
Coronary and peripheral stents, Pacing catheters, Vascular plugs - Acute Myocardial Infarction, Restenoses, Coronary
RecruitingAbbott Medical Devices37842020-10-252026-10-13
SELUTION SLR™ 014 In-stent Restenosis
SELUTION SLR 014 DEB, Standard of Care - Coronary Restenosis
Not applicableActive not recruitingM.A. Med Alliance S.A.4182020-07-062026-10-20
Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR
Indication of revascularization - Coronary Artery Disease, Left Main Coronary Artery Stenosis
Active not recruitingFundación EPIC3002019-02-192025-03-05
Metal Allergy In-Stent Restenosis Study
In-stent restenosis - Metal Allergy, Contact Allergy
Not applicableUnknownSilesian Centre for Heart Diseases10002018-10-012018-07-17
Treatment of In-Stent Restenosis 2 Study
sirolimus-eluting balloon (SEB) MagicTouch, paclitaxel-eluting balloon (PEB) Sequent Please - Coronary Restenosis
Phase 3CompletedUniversity Hospital Ostrava2002018-10-012022-12-07
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Percutaneous coronary intervention - Acute Coronary Syndrome, Angina Pectoris
CompletedFoundation of Cardiovascular Research and Education Enschede17572018-09-212026-02-06

Showing 20 of 107. Sign in to see all of them.

Narrower conditions

Coronary Artery Disease (72)  ·  Coronary Stenosis (53)  ·  Coronary Disease (38)  ·  Myocardial Ischemia (37)  ·  Vascular Diseases (27)  ·  Angina Pectoris (10)  ·  Angina, Unstable (9)  ·  Acute Coronary Syndrome (6)  ·  Cardiovascular Diseases (5)  ·  Coronary Thrombosis (4)  ·  Disease Progression (4)  ·  Myocardial Infarction (4)  ·  Arteriosclerosis (3)  ·  Atherosclerosis (3)

Broader conditions

Heart Diseases (105)  ·  Cardiovascular Diseases (102)  ·  Vascular Diseases (80)  ·  Arterial Occlusive Diseases (73)  ·  Arteriosclerosis (72)  ·  Myocardial Ischemia (70)  ·  Coronary Disease (69)  ·  Coronary Stenosis (54)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Neurologic Manifestations (11)  ·  Pain (11)  ·  Pathologic Processes (11)  ·  Signs and Symptoms (11)  ·  Chest Pain (10)  ·  Embolism and Thrombosis (5)

Interventions

Percutaneous Coronary Intervention (6)  ·  Drug-Eluting Stents (2)  ·  Immunosuppression Therapy (2)  ·  Secondary Prevention (2)  ·  Sirolimus (2)  ·  2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1)  ·  2,3-dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Aspirin (1)  ·  BEP protocol (1)  ·  Blood Specimen Collection (1)  ·  Brachytherapy (1)  ·  Celecoxib (1)  ·  Clopidogrel (1)  ·  Diagnostic Imaging (1)

Sponsors

Abbott Medical Devices (39)  ·  Foundation of Cardiovascular Research and Education Enschede (4)  ·  Peking Union Medical College Hospital (4)  ·  Deutsches Herzzentrum Muenchen (3)  ·  Biosensors Europe SA (2)  ·  Biotronik AG (2)  ·  Luzerner Kantonsspital (2)  ·  Medical Care Center Prof. Mathey, Prof. Schofer, Ltd. (2)  ·  North Texas Veterans Healthcare System (2)  ·  Scripps Health (2)  ·  Thorax Centrum Twente (2)  ·  University Hospital, Saarland (2)  ·  Aziende Chimiche Riunite Angelini Francesco S.p.A (1)  ·  B. Braun Medical Inc. (1)  ·  Best Vascular, Inc. (1)

Countries

United States (30)  ·  Germany (25)  ·  Netherlands (20)  ·  France (15)  ·  Italy (15)  ·  Belgium (14)  ·  Switzerland (14)  ·  China (12)  ·  Spain (11)  ·  Australia (10)  ·  Poland (10)  ·  Canada (9)  ·  Denmark (8)  ·  United Kingdom (8)  ·  Austria (7)

Top investigators

Gregg W Stone, MD (5)  ·  Bruno Scheller, MD (3)  ·  James Hermiller, MD (3)  ·  Mitch Krucoff, MD (3)  ·  Patrick Serruys, MD (3)  ·  Zhenyu Liu, M.D. (3)  ·  A. Pieter Kappetein, MD (2)  ·  Alexandre Abizaid, MD (2)  ·  Antonio Colombo, MD (2)  ·  Ashok Seth, MD (2)  ·  Corrado Vassanelli, MD (2)  ·  Dean J Kereiakes, MD (2)  ·  Eberhard Grube, MD (2)  ·  Emmanouil S Brilakis, MD, PhD (2)  ·  Flavio Ribichini, MD (2)

Results publications

PMID 25940520, PMID 24746650, PMID 26825231, PMID 29089314, PMID 31561250, PMID 35641327, PMID 37619976, PMID 37745109, PMID 22017936, PMID 22115661, PMID 26585622, PMID 15893169, PMID 17101615, PMID 18082503, PMID 18307999, PMID 18536865, PMID 19737719, PMID 20442358, PMID 21232715, PMID 21232716, PMID 22440499, PMID 27418609, PMID 33893022, PMID 34717627, PMID 37675090, PMID 38598970, PMID 39959922, PMID 40687396, PMID 15302787, PMID 16531618, PMID 17261663, PMID 17470709, PMID 17478730, PMID 17503509, PMID 17909106, PMID 18042333, PMID 18086474, PMID 18342684, PMID 18360849, PMID 18430909, PMID 18679382, PMID 18765162, PMID 18926156, PMID 18992650, PMID 19110796, PMID 19171853, PMID 19262209, PMID 19281920, PMID 19284065, PMID 19286089

NIH funding

2008 (1)